超越被动会诊:结构化干预对金黄色葡萄球菌菌血症死亡率的额外影响
在一项纳入271例成人金黄色葡萄球菌菌血症患者的双向队列研究中,比较未实施菌血症项目、实施项目及在项目基础上追加结构化干预三组的依从性与死亡率。追加结构化干预组14天和30天粗死亡率分别为2%和5%,均显著低于其他两组,高依从性与更低死亡率相关。
要点
- 结构化干预追加后14天死亡率降至2%、30天降至5%
- 菌血症项目依从性>75%与14天和30天死亡风险降低独立相关
- 心衰、MRSA感染和持续性菌血症是死亡的独立危险因素
核心结论
- 对金黄色葡萄球菌菌血症实施标准化集束化干预并达到高依从性,与14天和30天死亡率降低相关。
- 追加针对集束化应用的结构化干预可在原有菌血症项目基础上进一步降低死亡率。
研究设计与样本
- 双向队列研究,纳入271例成人金黄色葡萄球菌菌血症患者。
- 队列包括回顾性无项目组、回顾性项目实施组和前瞻性追加结构化干预组。
- 采用多变量逻辑回归分析14天和30天粗死亡率的影响因素。
主要发现
- 14天死亡率在三组间分别为18%、7%、2%,P=0.002。
- 30天死亡率在三组间分别为20%、12%、5%,P=0.011。
- 14天死亡危险因素:心衰OR=7.63、MRSA感染OR=4.02、持续性菌血症OR=11.01。
- 30天死亡危险因素:心衰OR=2.27、MRSA感染OR=4.37、持续性菌血症OR=7.83。
- 保护因素:导管相关菌血症14天OR=0.16、30天OR=0.19;依从性>75% 14天OR=0.15、30天OR=0.199。
关键数值与推荐
- 集束化依从性>75%为保护因素,14天OR=0.15,30天OR=0.199。
- 干预及随访所需时间为每例患者50分钟(IQR 40-55分钟)。
临床怎么用
- 对金黄色葡萄球菌菌血症患者推行标准化集束化管理并监测依从性。
- 在被动会诊基础上增加结构化干预以促进集束化措施落实。
- 关注心衰、MRSA感染和持续性菌血症等高死亡风险因素。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some evidence-based bundles have tried to standardize the management of Staphylococcus aureus bacteraemia (SAB) to improve the outcome. The aim of our study was to analyse the additional impact on mortality of a structured intervention in patients with SAB. METHODS: Compliance with the bundle was evaluated in an ambispective cohort of patients with SAB, which included a retrospective cohort [including patients treated before and after the implementation of a bacteraemia programme (no-BP and BP, respectively)] and a prospective cohort (i-BP), in which an additional specific intervention for bundle application was implemented. Multivariate logistic regression was used to measure the influence of the independent variables including compliance with the bundle on 14 and 30 day crude mortality. RESULTS: A total of 271 adult patients with SAB were included. Mortality was significantly different among the three groups (no-BP, BP and i-BP): mortality at 14 days was 18% versus 7% versus 2%, respectively, P = 0.002; and mortality at 30 days was 20% versus 12% versus 5%, respectively, P = 0.011. The factors associated with 14 and 30 day mortality in multivariable analysis were heart failure (OR = 7.63 and OR = 2.27, respectively), MRSA infection (OR = 4.02 and OR = 4.37, respectively) and persistent bacteraemia (OR = 11.01 and OR = 7.83, respectively); protective factors were catheter-related bacteraemia (OR = 0.16 and OR = 0.19, respectively) and >75% bundle compliance (OR = 0.15 and OR = 0.199, respectively). Time required to perform the intervention and the follow-up was 50 min (IQR 40-55 min) per patient. CONCLUSIONS: High-level compliance with a standardized bundle of intervention for management of SAB that requires little time was associated with lower mortality at 14 and 30 days.
引用
- Pérez-Rodríguez MT, Sousa A, López-Cortés LE, et al. Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2019. PMID: 30689894. doi:10.1093/jac/dky556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。